Kiadis Pharma NV (Kiadis Pharma NV) Other Long-Term Liabilities : $6.85 Mil (As of Dec. 2020)

View and export this data going back to 2016. Start your Free Trial

What is Kiadis Pharma NV Other Long-Term Liabilities?

Kiadis Pharma NV's other long-term liabilities for the quarter that ended in Dec. 2020 was $6.85 Mil.

Kiadis Pharma NV's quarterly other long-term liabilities increased from Dec. 2019 ($8.29 Mil) to Jun. 2020 ($13.20 Mil) but then declined from Jun. 2020 ($13.20 Mil) to Dec. 2020 ($6.85 Mil).

Kiadis Pharma NV's annual other long-term liabilities increased from Dec. 2018 ($0.00 Mil) to Dec. 2019 ($8.29 Mil) but then declined from Dec. 2019 ($8.29 Mil) to Dec. 2020 ($6.85 Mil).

Kiadis Pharma NV Other Long-Term Liabilities Historical Data

The historical data trend for Kiadis Pharma NV's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kiadis Pharma NV Other Long-Term Liabilities Chart

Kiadis Pharma NV Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Other Long-Term Liabilities

Get a 7-Day Free Trial

Kiadis Pharma NV Semi-Annual Data
	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20
Other Long-Term Liabilities	Get a 7-Day Free Trial											-	-	-	-	-

Kiadis Pharma NV Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Kiadis Pharma NV Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Kiadis Pharma NV's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Kiadis Pharma NV (Kiadis Pharma NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (GREY:KIADF) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP

Website

https://www.kiadis.com

Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Kiadis Pharma NV (Kiadis Pharma NV) Headlines

No Headlines